AMPR sells attention, but its real product is continuity - the patient, unglamorous work that keeps brands culturally legible long after the launch party ends.
Optimising protects million-page migrations, teaches restaurant chains to win the search for dinner, and gives one percent of revenue to the planet. Its wager is that technical discipline and a conscience can occupy the same spreadsheet.
Behind Bet Nation, BetDeluxe and eight other Australian wagering brands sits a Melbourne company with its own technology arm. Its bigger bet is on the people and software that can keep the whole portfolio moving.
The Melbourne company behind Stake and KICK is joining gambling, livestreaming and game development under one roof. Its most useful lessons begin where the first version stopped working.
For a century, beef and lamb have been graded by a person squinting at a carcass. MEQ Solutions built the hardware and AI to give the industry a number it can trust - and got the USDA to sign off.
The Melbourne agency built its pitch around a nerve-rattling promise: improve a qualified client’s results by 30 percent within 90 days, or keep working for free. Behind the swagger is a tightly engineered business of funnels, media buying, conversion work and sales education.
The company behind Penfolds spent a decade buying wine brands. Now it is cutting three quarters of them - and betting the whole business on the bottles people are willing to pay the most for.
Atisama Therapeutics (formerly Rage Bio) is a Melbourne-based clinical-stage biotech developing precision splice-switching oligonucleotide (SSO) therapies for chronic inflammatory disease. Its lead asset, RB042, is an inhaled RNA drug that targets the RAGE receptor to treat chronic obstructive pulmonary disease (COPD) - a condition affecting hundreds of millions worldwide with few disease-modifying options. Spun out of a collaboration between IP Group Australia, Monash, Murdoch and the University of Western Australia, the company raised a $29M Series A in 2025 and advanced RB042 into Phase 1 clinical trials in 2026.
Andromeda Robotics is a Melbourne-founded, San Francisco-based robotics company building Abi, a colourful humanoid companion robot designed to reduce loneliness in aged care and assisted living. Abi holds conversations in more than 90 languages, remembers residents across visits, and runs group activities, working alongside care teams rather than replacing them. Founded in 2022 by Grace Brown, the company deploys Abi to care homes on a subscription basis and raised a $23M Series A in September 2025 led by Forerunner.

Zetaris is an Australian enterprise data company building an open, agentic data lakehouse that lets organizations query and prepare data across many disparate sources without moving or copying it. Founded in 2013 in Melbourne by Vinay Samuel and Jason Jaesung Jun, the platform uses federated, in-place querying with intelligent multi-engine routing (Spark, Trino, Presto, DuckDB) and a unified semantic layer to feed private, governed AI workloads. It positions itself as a control plane for enterprise AI rather than another business-intelligence tool.